Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Buyout
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Austria, Netherlands, Hungary, Croatia, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Healthcare
- Education
- Business Services
- Consumer
Investment Size:
100,000,000 to 300,000,000 USD
Investor Details Founded: 1994
Jacobs Capital is a prominent European private equity firm that focuses on investing in mid-market businesses with high growth potential. The firm operates with a flexible investment horizon and a hands-on approach, aiming to create lasting value through active ownership and strategic guidance. Jacobs Capital's investment strategy emphasizes partnering with exceptional management teams to drive sustainable growth and operational excellence.
The firm's investment portfolio spans several sectors, including healthcare, business services, consumer products, and education. Within the healthcare sector, Jacobs Capital has made significant investments in companies such as Helios Global Group, a full-service healthcare communications provider, and Stingray Healthcare, a leading European radiotherapy group. These investments reflect the firm's commitment to supporting businesses that offer innovative solutions and have the potential for international expansion.
Jacobs Capital's approach is characterized by its entrepreneurial drive, sector expertise, and a focus on building great companies for the long term. The firm seeks to identify businesses with compelling demand dynamics and differentiated business models, providing them with the capital, expertise, and international growth-oriented mindset necessary to achieve their full potential. Through its strategic investments and active partnership approach, Jacobs Capital continues to play a pivotal role in shaping the future of its portfolio companies across Europe.
Requirements
- Control or co-control investments
- Target equity deployment per investment ranges from €100 million to €300 million
- Focus on high-performing, cash-flow generating, and well-managed businesses
- Potential for sustainable growth through international expansion, add-on acquisitions, and operational improvements
- Preference for companies with differentiated business models and opportunities for outsized growth
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Helios Global Group
- Stingray Healthcare
- Colosseum Dental Group
- North American Dental Group
- MedEuropa
- Sanoptis
- Barry Callebaut
- Cognita
- Mammut
- Permian
- Vittoria
- Lovehoney Group
Mentioned In
-
$19.95
-
$19.95
-
$19.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Jacobs Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim